Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
DNA Microarrays02:34

DNA Microarrays

Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early versus deferred antiretroviral therapy initiation and long-term cardiovascular disease outcomes in people with HIV: The START study.

Open forum infectious diseases·2025
Same author

PDCD4 regulates axonal growth by translational repression of neurite growth-related genes and is modulated during nerve injury responses.

RNA (New York, N.Y.)·2020
Same author

Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial.

The lancet. HIV·2018
Same author

A randomized trial comparing concise and standard consent forms in the START trial.

PloS one·2017
Same author

Different Array CGH profiles within hereditary breast cancer tumors associated to BRCA1 expression and overall survival.

BMC cancer·2016
Same author

Survivin expression promotes VEGF-induced tumor angiogenesis via PI3K/Akt enhanced β-catenin/Tcf-Lef dependent transcription.

Molecular cancer·2014
Same journal

A PAT-aligned framework for installing and operating particle counting systems to detect pre-limit particle-size distribution shifts in ISO-8 (non-sterile) controlled areas.

PDA journal of pharmaceutical science and technology·2026
Same journal

Using Positive Controls to Define the Defect Detection Range for CCIT Method Development and Validation.

PDA journal of pharmaceutical science and technology·2026
Same journal

Patient-Centric Drug Delivery: Establishing Injection Hold Time Limits for Large Volume Autoinjectors.

PDA journal of pharmaceutical science and technology·2026
Same journal

Gas flow through micro-capillaries â which flow law is most suitable to predict the flow rate through micro-capillaries?

PDA journal of pharmaceutical science and technology·2026
Same journal

Peer Review.

PDA journal of pharmaceutical science and technology·2026
Same journal

In-situ Verification of Disinfection Rotation for Contamination Control.

PDA journal of pharmaceutical science and technology·2026
See all related articles

Related Experiment Video

Updated: May 25, 2026

Using a Pan-Viral Microarray Assay (Virochip) to Screen Clinical Samples for Viral Pathogens
13:45

Using a Pan-Viral Microarray Assay (Virochip) to Screen Clinical Samples for Viral Pathogens

Published on: April 27, 2011

A microarray platform for virus detection and identification.

David Munroe1

  • 1Advanced Technology Program, SAIC-Frederick, Inc, National Cancer Institute at Frederick, Frederick, MD 21702.

PDA Journal of Pharmaceutical Science and Technology
|February 2, 2012
PubMed
Summary
This summary is machine-generated.

This workshop focused on adventitious virus detection and mitigation strategies for biologics. Key discussions centered on improving safety and regulatory approaches for biological products.

More Related Videos

Extracellular Protein Microarray Technology for High Throughput Detection of Low Affinity Receptor-Ligand Interactions
06:01

Extracellular Protein Microarray Technology for High Throughput Detection of Low Affinity Receptor-Ligand Interactions

Published on: January 7, 2019

ampliPHOX Colorimetric Detection on a DNA Microarray for Influenza
09:32

ampliPHOX Colorimetric Detection on a DNA Microarray for Influenza

Published on: June 9, 2011

Related Experiment Videos

Last Updated: May 25, 2026

Using a Pan-Viral Microarray Assay (Virochip) to Screen Clinical Samples for Viral Pathogens
13:45

Using a Pan-Viral Microarray Assay (Virochip) to Screen Clinical Samples for Viral Pathogens

Published on: April 27, 2011

Extracellular Protein Microarray Technology for High Throughput Detection of Low Affinity Receptor-Ligand Interactions
06:01

Extracellular Protein Microarray Technology for High Throughput Detection of Low Affinity Receptor-Ligand Interactions

Published on: January 7, 2019

ampliPHOX Colorimetric Detection on a DNA Microarray for Influenza
09:32

ampliPHOX Colorimetric Detection on a DNA Microarray for Influenza

Published on: June 9, 2011

Area of Science:

  • Biologics and Biopharmaceuticals
  • Virology
  • Regulatory Science

Background:

  • Adventitious viruses pose a significant risk to the safety of biological products.
  • Effective detection and mitigation strategies are crucial for ensuring product safety and regulatory compliance.
  • Industry and regulatory bodies must collaborate to address emerging challenges in virus safety.

Purpose of the Study:

  • To convene experts to discuss current and future strategies for adventitious virus detection in biologics.
  • To identify challenges and propose solutions for mitigating viral contamination risks.
  • To foster collaboration between the Parenteral Drug Association (PDA) and the Food and Drug Administration (FDA) on virus safety.

Main Methods:

  • The workshop involved presentations and discussions among leading scientists and regulators.
  • Key topics included advanced detection technologies, risk assessment, and regulatory perspectives.
  • Case studies and best practices were shared to inform strategies.

Main Results:

  • Identified critical gaps in current adventitious virus detection methods.
  • Highlighted the need for harmonized approaches to virus safety testing.
  • Emphasized the importance of a risk-based approach to mitigation.

Conclusions:

  • Continuous improvement in detection and mitigation strategies is essential for biologics safety.
  • Enhanced collaboration between industry and regulatory agencies is vital.
  • Proactive management of adventitious virus risks is paramount for public health.